Radar (Research on Adverse Drug Events and Reports) (Paperback)


High Quality Content by WIKIPEDIA articles The aims of the Research on Adverse Drug events And Reports (RADAR) Project are to disseminate safety reports for serious adverse drug reactions (sADRs) and to identify barriers to identification and reporting of these clinical events. Investigators have developed a well-coordinated system to accurately compile case report information on sADRs and to identify milestones associated with identification and reporting of the relevant ADR information. This ADR identification system allows us to amass pertinent sADR information from a diverse set of data sources in order to identify and report sADRs in a timely and thorough manner. With increasingly shortened review periods, post-marketing surveillance for sADRs has become very important. In some instances, initial cases are identified at hospital case conferences and reported to the FDA or to the pharmaceutical manufacturer. The RADAR methodology relies on initial recognition of these "sentinel" cases that then prompts hypothesis-driven inquiries as to whether an unrecognized adverse drug event signal is present in the population of those exposed to that drug.

R888

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles8880
Mobicred@R83pm x 12* Mobicred Info
Free Delivery
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

High Quality Content by WIKIPEDIA articles The aims of the Research on Adverse Drug events And Reports (RADAR) Project are to disseminate safety reports for serious adverse drug reactions (sADRs) and to identify barriers to identification and reporting of these clinical events. Investigators have developed a well-coordinated system to accurately compile case report information on sADRs and to identify milestones associated with identification and reporting of the relevant ADR information. This ADR identification system allows us to amass pertinent sADR information from a diverse set of data sources in order to identify and report sADRs in a timely and thorough manner. With increasingly shortened review periods, post-marketing surveillance for sADRs has become very important. In some instances, initial cases are identified at hospital case conferences and reported to the FDA or to the pharmaceutical manufacturer. The RADAR methodology relies on initial recognition of these "sentinel" cases that then prompts hypothesis-driven inquiries as to whether an unrecognized adverse drug event signal is present in the population of those exposed to that drug.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Betascript Publishing

Country of origin

United States

Release date

November 2010

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

November 2010

Editors

, ,

Dimensions

152 x 229 x 5mm (L x W x T)

Format

Paperback - Trade

Pages

80

ISBN-13

978-6131156304

Barcode

9786131156304

Categories

LSN

6131156301



Trending On Loot